Yaz Lawsuit Updates

Opening arguments in transvaginal mesh case

Opening arguments took place in the court case involving a woman who needed 18 operations to repair damage from a transvaginal mesh implant.

Her lawyer alleged that manufacturer Johnson & Johnson sold the device, which is supposed to shore up weakened pelvic muscles, after testing it inadequately and failing to warn of all the risks.

A Bloomberg story quotes him as saying: “They knew every single catastrophe before it ...

continue reading...

Increase in strokes among younger people

According to a story by Channel 6 Action News out of Philadelphia, there’s been an alarming increase in the number of relatively young people suffering strokes.

The story cites figures by the Center for Disease Control, which found the rate of people hospitalized for stroke between the ages of 15 and 44 has gone up 37 percent between 1995 and 2008.

The report includes an interview with a local woman, Kathy Doyle, who ...

continue reading...

Federal Yaz/Beyaz cases number more than 10,000

According to the Website for the U.S. District Court in the Southern District of Illinois, consolidated federal cases related to the Yasmin line of birth control pills now number more than 10,000.

Plaintiffs in the cases are seeking legal redress against pharmaceutical giant Bayer over blood clots from the Yaz/Yasmin contraceptives.

Lawyers suing the company cite FDA reports of at least 50 deaths tied to the pills from 2004 to 2008, claiming Bayer ...

continue reading...

Yaz lawsuits affect Bayer profits for 2nd quarter

Bayer’s second quarter earnings are down, largely because of costs associated with settling lawsuits from consumers who claim the pharmaceutical giant’s Yasmin line of birth control pills caused health problems, the Pittsburgh Post Gazette reports.

Despite the lagging profits, however, the company said global sales for the quarter jumped by 10 percent to a record $12.5 billion on strong performances by all three of the company’s business segments. Crop sciences revenues was ...

continue reading...

Yasmin settlements reach more than $402 million

According to a Bloomberg report, Bayer has said that settlements of U.S. lawsuits over its Yasmin line of birth control pills have reached more than $402 million.

The German pharmaceutical giant has resolved almost 1,900 cases involving allegations that its contraceptives caused potentially deadly blood clots, the company said this week in a stockholders’ newsletter. Bayer said it has paid $402.6 million in settlements of one category of clot cases, for an ...

continue reading...

Mother attributes daughter’s death to Yaz

News Channel 5 out of Cleveland reported on the death of 25-year-old Shantinique Burns, which her mother attributes to her use of the birth control pill Yaz.

Doctors say Shantinique suffered an aneurysm while driving. The report quotes her mother as saying the young woman had no health problems, and that Yaz was the only medication she was using.

“This is a side effect,” her mother said. “It is her cause of death.”

An ...

continue reading...
Page 1 of 8 12345...»